46 results
424B3
SLGL
Sol-Gel Technologies Ltd.
19 Aug 24
Prospectus supplement
6:03am
with its U.S. subsidiary, the Company) is an Israeli Company incorporated in 1997.
The Company is an innovative dermatology company with a successful
6-K/A
EX-99.2
SLGL
Sol-Gel Technologies Ltd.
19 Aug 24
Sol-Gel Reports Second Quarter 2024 Financial
6:01am
Technologies Ltd. (collectively with its U.S. subsidiary, the Company) is an Israeli Company incorporated in 1997.
The Company is an innovative dermatology
6-K
EX-99.2
SLGL
Sol-Gel Technologies Ltd.
16 Aug 24
Sol-Gel Reports Second Quarter 2024 Financial
7:15am
Technologies Ltd. (collectively with its U.S. subsidiary, the Company) is an Israeli Company incorporated in 1997.
The Company is an innovative dermatology
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd.
16 May 24
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to
6:15am
as an innovative combination formulation approved by the U.S. FDA, and its efficacy in treating acne has been proven by clinical trials. Beimei Pharma will perform … portfolio and pipeline, including 4 approved drugs launched in the market, and several innovative drugs with global rights and independent intellectual
424B3
SLGL
Sol-Gel Technologies Ltd.
4 Apr 24
Prospectus supplement
9:05am
into this prospectus.
Our Company
We are a dermatology company leveraging innovative approaches to develop pioneering treatments for patients with severe skin
POS AM
w1hpoq5jjc
20 Mar 24
Prospectus update (post-effective amendment)
4:05pm
6-K
EX-99.1
b58nhgxvsei
13 Mar 24
Sol-Gel Reports Full-Year 2023 Financial Results and 2023 - Corporate Highlights and Recent Developments
8:34am
6-K
EX-99.1
bxscsv
30 Nov 23
Current report (foreign)
7:10am
424B3
stxvhs 8zm8
9 Nov 23
Prospectus supplement
3:41pm
6-K
EX-99.1
6xp we5cznce55pozkx
9 Nov 23
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:15am
424B3
1lctzctyo9k6fq
10 Aug 23
Prospectus supplement
7:20am
6-K
EX-99.1
r56z16sdpx3 b4nxpbf
10 Aug 23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
6-K
EX-99.1
hxum746i23c
6 Jun 23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to
7:15am
424B3
218yb5a5r2quy2
12 May 23
Prospectus supplement
9:15am
6-K
EX-99.1
zdxrv6
12 May 23
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides
12:00am
6-K
EX-99.1
8opgd1028g3cv4a 0eh
4 Aug 22
Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
9:32am
6-K
EX-99.1
wc45rc
8 Jun 22
Current report (foreign)
7:15am
6-K
EX-99.1
ycc8pl0poa nwmjr
16 May 22
Current report (foreign)
7:35am
6-K
EX-99.1
z7kwhtmglx
13 May 22
Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:05am